Download PDF
1 / Pages

Other users also viewed these articles

Prevalence of atherogenic dyslipidemia, related factors and level of lipid control in the general population of Galicia. GALIPEMIAS study Carlos Názara; Rosa M. Argüeso; Juan Pedro-Botet; Xavier Pintó; Jesús Millán; Marta Pena Seijo; Pablo A. Fernández; M. Eugenia Ameneiros; Alberto del Alamo; Avelino Rodríguez; José Antonio Díaz-Peromingo; María Rosa Vázquez Freire; Javier Muñiz; Teresa R. Pérez-Castro; José Luis Díaz-Díaz; Antonio Pose Reino;
Clin Investig Arterioscler. 2023;35:178-84
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias Juan Pedro-Botet; Juan F. Ascaso; Mariano Blasco; Ángel Brea; Ángel Díaz; Antonio Hernández-Mijares; Xavier Pintó; Jesús Millán;
Clin Investig Arterioscler. 2020;32:209-18
Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®) Xavier Pintó; Luis Masana; Fernando Civeira; José Real; Daiana Ibarretxe; Beatriz Candas; José Puzo; José Luis Díaz; Núria Amigó; Margarita Esteban; Pedro Valdivielso;
Clin Investig Arterioscler. 2020;32:219-29